Parallax Volatility Advisers
SGMO

Parallax Volatility Advisers’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Parallax Volatility Advisers’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,421
Closed -$38.7K – 1653
2021
Q1 		$43K Sell
3,421
-1,099
-24% -$14.8K ﹤0.01% 1185
2020
Q4 		$71K Sell
4,520
-19,712
-81% -$231K ﹤0.01% 2008
2020
Q3 		$229K Buy
+24,232
New +$262K ﹤0.01% 2502
2019
Q3 		– Sell
-7,900
Closed -$85K – 3323
2019
Q2 		$85K Buy
+7,900
New +$84K ﹤0.01% 1893
2019
Q1 		– Sell
-59,217
Closed -$680K – 3882
2018
Q4 		$680K Buy
+59,217
New +$736K ﹤0.01% 1434
2018
Q3 		– Sell
-162,868
Closed -$2.48M – 3465
2018
Q2 		$2.31M Buy
+162,868
New +$2.71M ﹤0.01% 856
2018
Q1 		– Sell
-12,810
Closed -$210K – 3969
2017
Q4 		$210K Buy
+12,810
New +$191K ﹤0.01% 2248
2015
Q3 		– Sell
-10,922
Closed -$121K – 3977
2015
Q2 		$121K Buy
+10,922
New +$141K ﹤0.01% 2190

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parallax Volatility Advisers's SGMO Position: Q2 2021 in Review

Parallax Volatility Advisers sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2021, closing a stake of 3,421 shares — an estimated $38.7K sold.

Parallax Volatility Advisers first reported a position in SGMO in Q2 2015 and held it in 8 quarters. The position peaked at $2.31M in Q2 2018. 197 funds tracked by Wall St. Rank hold SGMO as of Q2 2021.

  • Parallax Volatility Advisers reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 3,421 SANGAMO THERAPEUTICS INC shares in Q2 2021, an estimated $38.7K.
  • Parallax Volatility Advisers first reported a position in SANGAMO THERAPEUTICS INC in Q2 2015 and held it in 8 quarters.
  • Parallax Volatility Advisers's SANGAMO THERAPEUTICS INC position peaked at $2.31M in Q2 2018.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2021.

Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.